|
Volumn 148, Issue 3, 2008, Pages 220-233
|
Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: An update review for the U.S. Preventive Services Task Force
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ASCORBIC ACID;
CLINDAMYCIN;
ERYTHROMYCIN;
METRONIDAZOLE;
PLACEBO;
BACTERIURIA;
CLINICAL TRIAL;
COCHRANE LIBRARY;
DATA EXTRACTION;
DRUG WITHDRAWAL;
EVIDENCE BASED PRACTICE;
FUNDING;
HUMAN;
INTERNAL VALIDITY;
LOW BIRTH WEIGHT;
MEDICAL RESEARCH;
MEDLINE;
PREGNANCY OUTCOME;
PREGNANT WOMAN;
PREMATURE FETUS MEMBRANE RUPTURE;
PREMATURE LABOR;
PREVENTIVE HEALTH SERVICE;
PRIORITY JOURNAL;
QUALITY CONTROL;
RATING SCALE;
REFERENCE DATABASE;
REVIEW;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SCREENING;
STATISTICAL ANALYSIS;
STATISTICAL SIGNIFICANCE;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
VAGINAL PRURITUS;
VAGINITIS;
VULVOVAGINAL ITCHING;
FEMALE;
MASS SCREENING;
META ANALYSIS;
PREGNANCY;
PREGNANCY COMPLICATION;
PREMATURITY;
RISK FACTOR;
FEMALE;
HUMANS;
MASS SCREENING;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREMATURE BIRTH;
RISK FACTORS;
VAGINOSIS, BACTERIAL;
|
EID: 39349093014
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-3-200802050-00008 Document Type: Review |
Times cited : (82)
|
References (63)
|